Search

everythinglearnresearchcommunity

for

Search:↓

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

A male with aromatase deficiency improved bone health with estradiol treatment.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

DHT may increase the risk of heart disease and death in elderly men.